1. Sweden Stocks

  2. •

    Healthcare

  3. •

    Medical - Instruments & Supplies
Elekta AB (publ)

Elekta AB (publ)

EKTAF
Elekta AB (publ)US flagOther OTC
6.50
USD
- -
- -
2.39BMarket Cap
Elekta AB (publ)
EKTAF
(Other OTC)

Recent

price

6.50

P/E

ratio

- -

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
FRC
21.17
24.04
27.16
28.05
28.43
29.43
28.07
30.29
35.48
38.22
36.02
38.08
44.15
47.42
47.15
- -
43.74
Revenue per Share
2.76
3.26
3.52
3.01
1.45
0.36
0.33
3.53
3.14
2.84
3.28
3.02
2.47
3.41
0.62
- -
-1.36
Basic EPS, GAAP
1.98
1.34
3.48
1.44
2.21
1.01
2.74
4.06
2.52
0.66
4.46
1.18
1.05
2.14
2.24
- -
3.64
Free Cash Flow per Basic Share
0.75
1
1.27
2.02
2.02
0.51
0.53
1
1.4
1.8
1.8
2.2
2.4
2.4
2.4
- -
2.4
Dividend per Share
9.88
12.08
14.1
15
14.43
14.3
10.92
13.4
15.05
15.76
17.69
18.52
18.59
19.63
17.89
- -
- -
Book Value per Share
3.06
-3.85
-2.27
-1.54
-4.01
-4.72
-8.24
-5.73
-3.99
-3.55
-1.53
-3.53
-5.21
-6.69
-8.03
- -
-9.37
Tangible Book Value per Share
373
376
381
381
381
381
381
382
382
382
382
382
382
382
382
- -
382
Basic Weighted Avg Shares
7,904
9,048
10,339
10,694
10,839
11,221
10,704
11,573
13,555
14,601
13,763
14,548
16,869
18,119
18,016
16,718
16,717
Sales/Revenue/Turnover
17.83
19.62
19.75
16.9
8.96
10.57
12.29
15.59
13.1
13.39
13.15
10.23
11.06
12.47
5
0.6
0.62
Operating Margin (%)
241
295
349
414
512
634
655
675
943
1,275
1,204
1,039
1,062
1,136
1,300
1,249
1,250
Depreciation Expense
1,031
1,227
1,340
1,148
552
137
125
1,348
1,198
1,084
1,254
1,154
943
1,302
237
-519
-519
Net Income, GAAP
29.58
28.1
24.94
23.3
22.07
23.28
62.94
19.81
24.18
25.45
23.13
22.98
21.2
21.88
51.02
- -
48.19
Effective Tax Rate (%)
13.04
13.56
12.96
10.73
5.09
1.22
1.17
11.65
8.84
7.42
9.11
7.93
5.59
7.19
1.32
-3.1
-3.1
Profit Margin (%)
1,833
3,050
3,391
3,473
2,965
721
1,290
1,409
1,000
4,266
1,306
1,324
1,669
-38
1,069
-1,961
-1,961
Working Capital
782
4,417
4,340
4,361
4,958
3,065
5,272
4,369
3,558
8,144
3,897
4,940
6,418
5,902
7,156
4,138
4,138
LT Debt
3,833
5,009
5,560
6,257
6,645
6,412
5,561
6,987
7,778
8,113
8,195
8,915
9,733
10,780
8,847
7,148
7,148
Total Equity
21.22
17.57
15.37
13.07
6.42
7.58
4.4
12.52
10.97
9.66
8.49
7.68
9.22
9.93
2.47
- -
- -
Return on Invested Capital (%)
24.91
20.06
15.46
12.9
6.57
2.85
2.03
14.86
12.68
9.68
10.11
9.82
8.94
11.09
2.99
- -
8.17
Return on Capital (%)
30.85
29.79
27.02
20.71
9.84
2.5
2.6
29.05
22.05
18.42
19.62
16.68
13.3
17.83
3.31
-15.18
-15.18
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Oct'26
Jan'26
Apr'26
ST Debt
1,096
2,038
3,193
LT Borrowings
5,647
4,458
3,380
LT Finance Leases
859
788
758
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
382
382
382
Market Capitalization
18,227
22,164
21,963

Working Capital

FRC

•

in mil. unless spec.
Oct'26
Jan'26
Apr'26
Total Current Assets
13,034
13,030
13,102
Cash, Cash Equivalents & STI
2,576
2,541
3,189
Accounts Receivable, Net
3,324
3,772
3,688
Inventories
3,086
3,019
2,876
Total Current Liabilities
12,564
13,753
15,063
Payables & Accruals
- -
- -
- -
ST Debt
1,096
2,038
3,193
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
2.06%
-1.68%
-19.2%
Free Cash Flow
77.05%
17.38%
62.62%
Net Income, GAAP
57.57%
-77.79%
-318.99%
Sales/Revenue/Turnover
4.39%
4.26%
-7.2%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
3,828
4,732
4,537
5,023
18,119
2025
3,825
4,341
4,695
5,156
18,016
2026
3,646
4,070
4,239
4,762
16,718

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.62
0.9
0.8
1.08
3.41
2025
0.18
0.55
0.89
-1.01
0.62
2026
0.28
0.6
0.03
-2.27
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
1.2
- -
1.19
2.4
2025
- -
1.19
- -
1.2
2.4
2026
- -
1.19
- -
1.2
- -
Similar Companies
iZafe Group AB (publ) (IZAFE-B.ST)
Kossan Rubber Industries Bhd (7153.KL)
Well Lead Medical Co., Ltd. (603309.SS)
Nissan Medical Industries Ltd (NISA.TA)
Straumann Holding AG (0QMV.L)
Becton, Dickinson and Company (BDXA)
Business
Elekta AB (publ) (EKTAF) develops, manufactures and markets clinical solutions for treating cancer and brain disorders worldwide. The company provides radiation therapy systems including linear accelerators such as Versa HD and Unity MR-Linac for magnetic resonance-guided radiation therapy; radiosurgery solutions like Leksell Gamma Knife Icon and Vantage for stereotactic treatments; brachytherapy products including Esteya and Flexitron systems; and oncology software platforms such as MOSAIQ OIS for patient management, RayStation for treatment planning, and Mona Lisa for gynecological brachytherapy guidance. Elekta offers related services encompassing installation, maintenance, training, and upgrades; positioning and immobilization devices through its Elekta One platform; and workflow optimization tools for precision radiation oncology. Founded in 1972 and headquartered in Stockholm, Sweden, the company operates in over 120 countries, serving hospitals, cancer centers and academic institutions primarily in North America, Europe and Asia-Pacific. In recent developments, Elekta completed the acquisition of Classiq, a quantum computing software provider, in fiscal year 2025 to advance AI and quantum applications in radiation therapy planning. The company launched the Elekta Harmony system, a compact linear accelerator, and expanded its MR-Linac capabilities with software upgrades enhancing adaptive radiotherapy workflows. Elekta forged strategic partnerships, including with ViewRay for imaging integration and Siemens Healthineers for joint distribution in select markets, while securing a major multi-year contract with the U.S. Department of Veterans Affairs for Gamma Knife installations.

Company News

APIChat

  • seekingalpha.com

    Elekta AB (publ) (EKTAY) Q4 2026 Earnings Call Transcript

  • seekingalpha.com

    Elekta AB (publ) (EKTAF) Q1 2026 Earnings Call Transcript

  • seekingalpha.com

    Elekta AB (publ) (EKTAF) Q4 2025 Earnings Call Transcript

  • seekingalpha.com

    Elekta AB (publ) (EKTAF) Q3 2025 Earnings Call Transcript

  • seekingalpha.com

    Elekta AB (publ) (EKTAF) Q2 2025 Earnings Call Transcript

  • seekingalpha.com

    Elekta AB (publ) (EKTAF) Q1 2025 Earnings Call Transcript

  • seekingalpha.com

    Elekta AB (publ) (EKTAF) Q4 2024 Earnings Call Transcript